These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8653481)

  • 21. Oral ganciclovir for cytomegalovirus retinitis.
    Torgovnick J
    N Engl J Med; 1996 Jan; 334(1):55-6. PubMed ID: 7494578
    [No Abstract]   [Full Text] [Related]  

  • 22. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral ganciclovir for cytomegalovirus retinitis.
    Van Natta ML; Holbrook J
    N Engl J Med; 1996 Jan; 334(1):55; author reply 55-6. PubMed ID: 7494577
    [No Abstract]   [Full Text] [Related]  

  • 24. Ganciclovir. A pharmacoeconomic review of its use as intravenous or oral maintenance therapy in the management of cytomegalovirus retinitis in patients with AIDS.
    Perry CM; Davis R
    Pharmacoeconomics; 1997 Aug; 12(2 Pt 1):209-28. PubMed ID: 10169672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local therapy for cytomegalovirus retinitis.
    Smith CL
    Ann Pharmacother; 1998 Feb; 32(2):248-55. PubMed ID: 9496411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An economic analysis of managed fee-for-service and direct reimbursement.
    van der Wal CJ; Smithwick CL
    J Am Coll Dent; 1997; 64(3):28-36. PubMed ID: 9420385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
    Drew WL; Stempien MJ; Andrews J; Shadman A; Tan SJ; Miner R; Buhles W
    J Infect Dis; 1999 Jun; 179(6):1352-5. PubMed ID: 10228054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral ganciclovir.
    Schouten JT
    STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ganciclovir implant in the treatment of cytomegalovirus retinitis.
    Chang M; Dunn JP
    Expert Rev Med Devices; 2005 Jul; 2(4):421-7. PubMed ID: 16293081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS.
    Lee TA; Sullivan SD; Veenstra DL; Ramsey SD; Steger PJ; Malinverni R; Pleil AM; Williamson T
    Pharmacoeconomics; 2001; 19(5 Pt 2):535-50. PubMed ID: 11465299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ganciclovir evaluation in AIDS patients with cytomegalovirus retinitis: a European study of treatment patterns and resource utilization.
    Hardens M
    AIDS; 1996 Dec; 10 Suppl 4():S25-30. PubMed ID: 9110067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDA clears retinal implant for CMV.
    AIDS Patient Care STDS; 1996 Jun; 10(3):191. PubMed ID: 11361641
    [No Abstract]   [Full Text] [Related]  

  • 33. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation. Comparing valaciclovir prophylaxis with current practice.
    Mauskopf JA; Richter A; Annemans L; Maclaine G
    Pharmacoeconomics; 2000 Sep; 18(3):239-51. PubMed ID: 11147391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CMV trial enrolling.
    Vazquez E
    Posit Aware; 1997; 8(4):13. PubMed ID: 11364480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinic provision of contraceptive services to managed care enrollees.
    Frost JJ
    Fam Plann Perspect; 1998; 30(4):156-62. PubMed ID: 9711452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [High-dose intravitreal ganciclovir in CMV retinitis].
    Cochereau I; Diraison MC; Mousalatti H; Bouyer I; Ren L; Guvenisik N; Hoang-Xuan T
    J Fr Ophtalmol; 2000 Feb; 23(2):123-6. PubMed ID: 10705113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained-release ganciclovir implants represent an effective treatment option for many patients with cytomegalovirus (CMV) retinitis.
    Polk TD; Russell SR; Gehrs KM; Folk JC
    Retina; 1997; 17(5):463-4. PubMed ID: 9355202
    [No Abstract]   [Full Text] [Related]  

  • 39. New drug for CMV in trials.
    Treat Rev; 1995 Jan; (no 16):3. PubMed ID: 11362288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral ganciclovir: role in maintenance therapy for CMV retinitis in AIDS patients.
    Owens RC; Ross JW
    Conn Med; 1996 Nov; 60(11):663-5. PubMed ID: 8979433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.